Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants
Phase 1
Recruiting
- Conditions
- Pharmacokinetics Study on Healthy Volunteers Adults
- Interventions
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Antabio
- Target Recruit Count
- 25
- Registration Number
- NCT06916156
- Locations
- 🇺🇸
Pulmonary Associates, PA, Phoenix, Arizona, United States
Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Antabio
- Target Recruit Count
- 48
- Registration Number
- NCT06527677
- Locations
- 🇩🇪
CRS Clinical Research Services Kiel GmbH, Kiel, Germany
FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Antabio
- Target Recruit Count
- 72
- Registration Number
- NCT05905913
- Locations
- 🇫🇷
Biotrial, Rennes, France
© Copyright 2025. All Rights Reserved by MedPath